Xencor

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.

CEO

Bassil I. Dahiyat

CEOBassil I. Dahiyat

Employees

250

Employees250

Headquarters

Pasadena, California

HeadquartersPasadena, California

Founded

1997

Founded1997

Employees

250

Employees250

XNCR Key Statistics

Market cap

654.06M

Market cap654.06M

Price-Earnings ratio

-2.97

Price-Earnings ratio-2.97

Dividend yield

—

Dividend yield—

Average volume

713.03K

Average volume713.03K

High today

$9.46

High today$9.46

Low today

$9.01

Low today$9.01

Open price

$9.17

Open price$9.17

Volume

420.76K

Volume420.76K

52 Week high

$27.24

52 Week high$27.24

52 Week low

$7.16

52 Week low$7.16

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

Sell

8.3%

People also own

Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.